Crossmark

PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Chinese patients with advanced non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s12957-025-03934-8

Published Online: 2025-07-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Jianfei

Liu, Min

Li, Dongyang

Luo, Jiali

Wang, Min
License Information

Text and Data Mining valid from 2025-07-10

Version of Record valid from 2025-07-10
More Information

Article History

Received: 9 May 2025

Accepted: 29 June 2025

First Online: 10 July 2025

Declarations

:

: Not Applicable.

: The authors declare no competing interests.

: CRD420251038720.

: .

: Due to the nature of this study no ethical approval was required.

: The authors certify that there is no conflict of interest regarding this manuscript.

Document is current

Any future updates will be listed below